pyrrolidine dithiocarbamate has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, E; Katano, M; Kuga, H; Kuroki, H; Matsumoto, K; Morisaki, T; Onishi, H; Sasaki, N; Tanaka, M | 1 |
| Chen, D; Daniel, KG; Dou, QP; Yan, B | 1 |
1 review(s) available for pyrrolidine dithiocarbamate and Neoplasms
| Article | Year |
|---|---|
Copper-binding compounds as proteasome inhibitors and apoptosis inducers in human cancer.
Topics: Antineoplastic Agents; Apoptosis; Clioquinol; Copper; Humans; Neoplasms; Neovascularization, Pathologic; Oxyquinoline; Protease Inhibitors; Proteasome Inhibitors; Pyrrolidines; Thiocarbamates | 2007 |
1 other study(ies) available for pyrrolidine dithiocarbamate and Neoplasms
| Article | Year |
|---|---|
Monocyte-derived dendritic cells that capture dead tumor cells secrete IL-12 and TNF-alpha through IL-12/TNF-alpha/NF-kappaB autocrine loop.
Topics: Apoptosis; Cell Line, Tumor; Cells, Cultured; Dendritic Cells; Humans; Interleukin-12; Monocytes; Necrosis; Neoplasms; NF-kappa B; Pyrrolidines; Thiocarbamates; Tumor Necrosis Factor-alpha | 2004 |